Skip to Content

Ixazomib Disease Interactions

There are 5 disease interactions with ixazomib:

Moderate

Ixazomib (Includes Ixazomib) ↔ Gastrointestinal Toxicities

Moderate Potential Hazard, Moderate plausibility

Applies to: Diarrhea, Vomiting, Constipation

Ixazomib may cause diarrhea, constipation, nausea, and vomiting. Care should be taken when using this agent in patients experiencing gastrointestinal complications. It is recommended to adjust the dose of this agent as per the manufacturer dosing instructions for Grade 3 or 4 symptoms. Evaluate for underlying causes and provide supportive care as necessary.

Moderate

Ixazomib (Includes Ixazomib) ↔ Hepatic Impairment

Moderate Potential Hazard, Moderate plausibility

Applies to: Liver Disease

Pharmacokinetic studies of ixazomib in patients with moderate to severe hepatic impairment, showed an increase AUC when compared to patients with normal hepatic function. The pharmacokinetic of ixazomib was similar in patients with normal hepatic function and in patients with mild hepatic impairment. It is recommended to reduce the starting dose in patients with moderate to severe hepatic impairment. Caution should be exercised when ixazomib is administered to patients with moderate to severe hepatic function and monitoring of liver function tests is recommended as appropriate.

Moderate

Ixazomib (Includes Ixazomib) ↔ Peripheral Neuropathy

Moderate Potential Hazard, Moderate plausibility

Applies to: Peripheral Neuropathy

Peripheral neuropathy has been reported with the use of ixazomib. Patients should be monitored for symptoms of neuropathy and if they are experiencing new or worsening peripheral neuropathy, it is recommended to withhold therapy and modify the dose as per manufacturer instructions.

Moderate

Ixazomib (Includes Ixazomib) ↔ Renal Impairment

Moderate Potential Hazard, Moderate plausibility

Applies to: Renal Dysfunction

Population PK analysis in patients with severe renal impairment or ESRD requiring dialysis showed an increase AUC when compared to patients with normal renal function. The pharmacokinetic of ixazomib was similar in patients with normal renal function and in patients with mild or moderate renal impairment. It is recommended to reduce the starting dose in patients with severe renal impairment or ESRD requiring dialysis. Caution should be exercised when ixazomib is administered to patients with severe renal impairment. Ixazomib is not dialyzable and therefore can be administered without regard to the timing of dialysis

Moderate

Ixazomib (Includes Ixazomib) ↔ Thrombocytopenia

Moderate Potential Hazard, Moderate plausibility

Applies to: Thrombocytopenia

Thrombocytopenia has been reported with the use of ixazomib. It is recommended to monitor platelet counts regularly during treatment and to considered withholding therapy or dosage modifications and platelet transfusions as per manufacturer recommendations and clinical guidelines.

ixazomib drug Interactions

There are 275 drug interactions with ixazomib

ixazomib alcohol/food Interactions

There is 1 alcohol/food interaction with ixazomib

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. Multum's information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill, knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2017 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide